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Abstract   
The importance of the role played by bacteria in the pathogenesis of pulpal and apical disease 
has been established. One of the characteristics of apical periodontitis is apical bone resorption, 
which is due to apical immune response to bacterial infection. Recently, novel bacterial complex 
lipid called phosphorylated dihydroceramides has been discovered to be of inflammatory 
activators. The bacterial lipids stimulate prostaglandin E2, IL-6, and TNF-α secretion, inhibit 
osteoblast differentiation and function, and induce osteoclast formation. The biological activities 
are in Toll-like receptor 2 (TLR2)-dependent manner. These new findings imply that bacterial 
lipids could be important virulent factors that cause apical bone resorption. Future investigations 
may determine the significance of the bacterial lipids in the pathogenesis and treatment of 
endodontic diseases. [Iranian Endodontic Journal 2010;5(4):141-6] 
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Novel bacterial complex lipids called 
phosphorylated dihydroceramides have been 
recently discovered to be inflammatory 
activator. In this review the regulation of 
osteoblast and osteoclast differentiation and 
Toll-like receptors will be first introduced, as 
the activities of the bacterial lipids involve 
these two fields. Subsequently, recent and fresh 
findings of the biological activities of bacterial 
lipids and the implications for the pathogenesis 
of apical periodontitis will be summarized.  
Regulation of osteoblast and osteoclast 
differentiation and bone resorption 
One of the characteristics of apical 
periodontitis is apical bone resorption. Bone is 
continuously remodeling to maintain bone 
volume and calcium homeostasis. Osteoblasts 
secrete and deposit bone matrix proteins 
including type I collagen, osteocalcin (OC), 
osteopontin (OPN), bone sialoprotein (BSP) 
and proteoglycans (1). Osteoblasts also 
regulate the formation of hydroxyapatite 
crystals with high enzyme activity of alkaline 
phosphatase (ALP) (1). Bone morphogenetic 
proteins (BMPs) are the key regulators of the 
differentiation of osteoblasts. BMPs enhance 
the expression of type I collagen, OC, and 
ALP (1). Transcription factor Runx2 is the key 
regulator of osteoblast differentiation by 
binding Runx consensus sequence in the 
promoter of all major osteoblast genes (2,3). 
BMP2 promotes Runx2 and Osterix 
expression (1). Osterix, activating 
transcription factor 4 (ATF4), and β-Catenin, 
which act downstream of Runx2, also play 
essential roles in osteoblast differentiation (2). 
In osterix deficient mice, there are no 
osteoblast differentiation and bone formation 
(4). Late-stage osteoblast differentiation, 
which is represented by gene expression of 
OC and BSP, is significantly inhibited by 
inactivation of c-jun N-terminal kinase (JNK) 
and down-regulation of ATF4 (5). Inactivation 
of β-Catenin stops mesenchymal progenitors 
differentiate to osteoblasts (6). 
Osteoclasts are large multinucleated 
specialized giant cells responsible for bone 
resorption that arise from a hematopoietic 
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stem cell lineage of monocytes and macrophages 
(7). Progenitor cells undergo a series of 
differentiation stages during the development of 
osteoclastogenesis (8). RANKL (receptor 
activator of nuclear factor kappa B ligand) and 
M-CSF (macrophage colony stimulating factor) 
are considered to be essential environmental 
factors during normal osteoclastogenesis (8,9). 
Osteoclast differentiation is mediated by 
RANKL/RANK/OPG axis (10,11). RANKL is 
expressed primarily on cell surface of bone 
marrow stromal cells and osteoblasts. RANK 
(receptor activator of nuclear factor kappa B) is 
mainly expressed in osteoclast precursors and 
mature osteoclasts. RANKL binds to its receptor 
(RANK) and activates several downstream 
signaling cascades leading to activation of 
several critical transcription factors that are 
required for osteoclast differentiation and 
activity (12). Transcription factor NFATc1 is the 
crucial regulator of osteoclastogenesis and 
stimulates osteoclast specific genes, such as 
tartrate resistant acid phosphatase         
(TRAP) and cathepsin K (CSK) (13). OPG 
(osteoprotegerin) is a protein that is secreted 
by osteoblasts. It binds to RANKL, occupies 
the binding site for RANK, and blocks its 
function. Mice deficient in RANK or RANKL 
have severe osteopetrosis with decreased 
osteoclasts (10,12,14). Mice deficient in OPG 
have profound osteoporosis with increased 
osteoclastogenesis (15). The expression of 
RANKL and OPG is highly modulated by 
multiple osteotropic agents and cytokines to 
tightly regulate osteoclast formation, activity, 
and survival (11,16). In states of 
inflammation, RANKL expression can be 
significantly up-regulated by osteoblasts in 
response to pro-inflammatory cytokines (17).  
M-CSF stimulates the expression of RANK on 
osteoclast precursors. M-CSF deficient mice 
are osteopetrotic due to defective osteoclast 
differentiation and activity (18,19). Recent 
findings support the notion that LPS and some 
inflammatory cytokines such as TNF-α and 
IL-1 may also be directly involved in 
osteoclast differentiation and activation 
through a mechanism partially independent 
from that of RANKL-RANK interaction. 
TNF-α and IL-1 act through their own 
respective receptors (16,20,21).  
Toll-like Receptors (TLRs) and bacterial 
virulent factors  
The innate immune system is the first line of 
host defense against pathogens. It recognizes 
microorganisms via pattern-recognition 
receptors (PRRs) (22). TLRs are one of several 
classes of PRRs (23). PRRs recognize 
microbial components, which are broadly 
shared by pathogens but distinguishable from 
host molecules, referred to as pathogen-
associated molecular patterns (PAMPs) 
(22,23). TLRs are expressed on various cells 
including macrophages, dendrite cells, B cells, 
certain types of T cells, fibroblasts, epithelial 
cells, and bone cells (22,23). To date, 13 TLRs 
have been identified (24). TLR4 is the LPS 
receptor. TLR2 recognizes a variety of 
microbial components, including lipoteichoic 
acid, lipoproteins, and peptidoglycan (22,23). 
Interaction of TLRs with their specific PAMPs 
induces the secretion of pro-inflammatory 
cytokines and expression of co-stimulatory 
molecules (22,23,25).  
Biological activity of novel complex lipids and 
implications for the pathogenesis of apical 
periodontitis  
Pulp infections initially produce an 
inflammatory response within the pulp that 
often leads to complete pulpal necrosis and 
subsequently in the apical region, which results 
in apical lesion formation (26). The 
significance of the role of microorganisms in 
the pathogenesis of pulpal and apical disease 
has been established by several classical studies 
(27-30). The development of anaerobic 
techniques and modern molecular methods for 
culturing, detecting, and characterizing 
organisms have revealed that the bacteria 
involved in primary endodontic infections are 
predominantly Gram-negative anaerobic species 
(31-35).  
The black-pigmented Gram-negative anaerobic 
bacteria such as Porphyromonas gingivalis 
(P.gingivalis), Porphyromonas endodontalis 
(P.endodontalis), Prevotella intermedia 
(P.intermedia) and Prevotella nigrescens 
(P.nigrescens) are relatively common in infected 
root canals and endodontic abscesses (32,36). 
Their presence in root canals or abscesses has 
been confirmed by traditional culture and 
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P.gingivalis and P.endodontalis have been 
closely associated with acute symptoms of 
endodontic infections (40,41). P.gingivalis and 
Fusobacterium nucleatum (F.nucleatum) have 
been detected as co-colonizers in biofilms 
associated with apical lesions (42). Recent 
studies have shown that P.gingivalis enhances 
biofilm formation by F.nucleatum, while F. 
nucleatum enhances attachment of P. gingivalis 
to the host cells (43,44). Their synergistic 
relationship is important in polymicrobial 
endodontic infections.  
Endodontopathogenic products of black-
pigmented anaerobic bacteria may include 
fimbriae, cell capsule, outer membrane proteins, 
and endotoxic lipopolysaccharides (45). LPS is 
one of the most studied microbial initiators of 
inflammation and endodontic pathogenesis (46-
53). LPS binds the TLR4/CD14/MD2 receptor 
complex and promotes the secretion of pro-
inflammatory cytokines, such as TNF-α, IL-1, 
and IL-6 in many cell types, especially in 
macrophages (54,55). Calcium hydroxide 
hydrolyzes the lipid moiety of LPS and alters the 
biological properties of LPS (56,57). Recently, it 
has been discovered that black pigmented 
bacteria synthesizes complex lipids, comprising 
a group of unusual sphingolipids called 
dihydroceramides that possess impressive 
capacity to stimulate the secretion of 
inflammatory cytokines, inhibit osteoblast 
differentiation, and promote osteoclastogenesis 
(58-60).  
Several novel complex lipids produced by 
P.gingivalis, termed phosphorylated 
dihydroceramides have been identified (61, 62). 
Three major classes of the ceramides are free 
(non-phosphorylated) dihydroceramides (DHC), 
phosphoglycerol dihydroceramide (PG DHC), 
and phosphoethanolamine dihydroceramide (PE 
DHC) (62). These lipids are also recovered from 
calculus-contaminated root surfaces (63,64) and 
from diseased periodontal tissues (65). These 
sphingolipids potentiate interleukin-1β (IL-1 β) 
mediated secretion of inflammatory mediators 
from fibroblasts, including prostaglandin E2, 
and alter gingival fibroblast morphology and 
adherence (61,66). Prostaglandin E2 is known to 
promote vasodilation, inflammatory responses 
and to stimulate osteoclast mediated bone 
resorption. Phosphoglycerol dihydroceramide is 
found to induce the apoptosis of human 
endothelial cells, which potentially account for 
the loss of attachment associated with 
periodontitis (67). The phosphorylated 
dihydroceramides, particularly the PE DHC, 
enhance the experimental allergic 
encephalomyelitis in the murine model of 
multiple sclerosis, and induce dendritic cell 
interleukin-6 secretion in a TLR2-dependent 
manner (58). These findings demonstrated that 
dihydroceramides may play important role in 
autoimmune diseases (58).  
Furthermore, P.gingivalis lipids inhibit 
osteoblast differentiation in a concentration-
dependent manner. However, P. gingivalis lipids 
do not significantly alter osteoblast proliferation, 
viability, or apoptosis (60). Real time PCR 
shows down-regulation of osteoblast genes 
including Runx2, ALP, OC, BSP, OPG and 
DMP-1 with concurrent up-regulation of 
RUNKL, TNF-α, and MMP-3 genes (60). The 
inhibitory effect of P.gingivalis lipids on 
osteoblast differentiation is attributed primarily 
to the PG DHC lipids and is shown to be 
dependent on TLR2 expression (60). Moreover, 
P.gingivalis lipids inhibit calvarial osteoblast 
gene expression and they act in-vivo (60).  
P.endodontalis produces analogous 
phosphorylated ceramide lipids as P.gingivalis 
with the exception of PG DHC, which P. 
endodontalis does not generate (68). Like 
P.gingivalis lipids, P.endodontalis lipids 
inhibit osteoblast differentiation through 
engagement of TLR2 (68). P.endodontalis and 
P.gingivalis lipids induce monocyte TNF-α 
secretion. Anti-TLR2, not anti-TLR4, 
antibody significantly reduced the effect of the 
lipids on monocytes as shown with the 
reduction of TNF-α production (68,69). 
P.endodontalis and P.gingivalis lipids also 
promote osteoblast cell differentiation and 
maturation (68,69). Again TLR2 antibody 
significantly reduced the number of the 
TRAP-positive multinucleated osteoclasts, 
which were induced by P.endodontalis and 
P.gingivalis lipids (69). The presence of the 
bacteria lipids in the infected root canals was 
investigated with the control of vital pulp tissues. 
The phosphoethanolamine dihydroceramide 
associated with P.endodontalis was identified 
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Conclusion  
In summary, the bacterial lipids stimulate 
inflammatory mediator secretion, such as 
prostaglandin E2, IL-6, and TNF-α, inhibit 
osteoblast differentiation and function, and 
induce osteoclast formation. The lipids were 
also identified from infected root canals. These 
findings imply that the bacteria lipids could be 
virulent factors for the pathogenesis of apical 
periodontitis. 
Future studies may determine the correlation 
between the bacteria lipids in root canals and 
the presence of apical lesions, the persistence 
of bacteria lipids in apical lesions, and the 
molecular mechanisms by which bacterial 
lipids cause apical bone resorption.  
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